4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-005751
Chief Financial Officer sold 100,000 shares at an average $65.05 ($6,505,456)
- Chief Financial Officer acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2021-01-25 | Option exercise | +50,000 | $6.32 | $316,000 | 51,000 | D |
| Cohen Chad M Chief Financial Officer | 2021-01-25 | Sale | −10,611 | $65.08 | $690,564 | 40,389 | D |
| Cohen Chad M Chief Financial Officer | 2021-01-25 | Sale | −20,953 | $65.69 | $1,376,403 | 19,436 | D |
| Cohen Chad M Chief Financial Officer | 2021-01-25 | Sale | −17,436 | $67.03 | $1,168,735 | 2,000 | D |
| Cohen Chad M Chief Financial Officer | 2021-01-25 | Sale | −1,000 | $67.68 | $67,680 | 1,000 | D |
| Cohen Chad M Chief Financial Officer | 2021-01-26 | Option exercise | +50,000 | $6.32 | $316,000 | 51,000 | D |
| Cohen Chad M Chief Financial Officer | 2021-01-26 | Sale | −10,318 | $62.71 | $647,042 | 40,682 | D |
| Cohen Chad M Chief Financial Officer | 2021-01-26 | Sale | −12,977 | $63.65 | $825,986 | 27,705 | D |
| Cohen Chad M Chief Financial Officer | 2021-01-26 | Sale | −20,785 | $64.54 | $1,341,464 | 6,920 | D |
| Cohen Chad M Chief Financial Officer | 2021-01-26 | Sale | −5,920 | $65.47 | $387,582 | 1,000 | D |
| Derivatives | |||||||
| Cohen Chad M Chief Financial Officer | 2021-01-25 | Option exercise · Stock Option (Right to Buy) | −50,000 | 215,000 | D | ||
| Cohen Chad M Chief Financial Officer | 2021-01-26 | Option exercise · Stock Option (Right to Buy) | −50,000 | 165,000 | D | ||
| Open-market sales · 100,000 sh · avg $65.05 · $6,505,456 | |||||||
Loading xslF345X03/doc4.xml…